Companies: 10,795·Total market cap: $144.5T
IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc.

IDXXNASDAQHealthcare● Active
$563.58
+$1.42(+0.25%)
Market Cap$44.5B
P/E Ratio
52W High$769.98
52W Low$506.91

IDEXX Laboratories, Inc. (IDXX) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

idxx · stock forecast · 22 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 22 Wall Street analysts in the past 3 months

SellBuy

Buy

22 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
13
Hold
8
Sell
1
Strong Sell
0
Total: 22 · Buy rate: 59.1%

12-Month Price Target

High

$800

Consensus

$748

+32.9% upside

Low

$640

Median: $775 · Last Close: $562.27

The IDEXX Laboratories, Inc. (IDXX) analyst consensus is Buy, based on ratings from 22 Wall Street analysts over the past 3 months. The average 12-month IDXX price target is $747.50, representing +32.9% upside from the current price of $562.27.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $748 (32.9%)

Consensus Target

$747.50

32.9% upside

High Target

$800

42.3%

Low Target

$640

13.8%

Current Price

$562.27

as of today

Based on analyst price targets, the IDXX stock price prediction for the next 12 months ranges from $640 to $800. The consensus IDXX price forecast of $747.50 implies 32.9% upside from the current price of $562.27.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$568.041.03%

1-day model range: $566.21–$569.88. Peak: $569.88 (+1.03%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$488-13.1%
2028$447-20.6%
2029$422-25.0%
2030$407-27.7%
2031-29.4%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

NEUTRAL

Based on 14 technical indicators

50%7%43%
7Buy
1Neutral
6Sell
RSI (14)60.3Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · IDXX · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$560.14BUY
MA 10$560.73BUY
MA 20$551.09BUY
MA 50$562.87SELL
MA 100$599.44SELL
MA 200$635.68SELL
Current $IDXX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$561.68BUY
EMA 10$559.86BUY
EMA 20$558.43BUY
EMA 50$568.50SELL
EMA 100$590.12SELL
EMA 200$597.75SELL
Current $IDXX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
UBS2026-04-28
Maintains
NeutralNeutral
Stifel2026-03-31
Maintains
BuyBuy
Piper Sandler2026-02-09
Maintains
NeutralNeutral
Barclays2026-02-05
Maintains
OverweightOverweight
UBS2026-02-03
Maintains
NeutralNeutral
BTIG2026-02-03
Maintains
BuyBuy
JP Morgan2025-11-04
Maintains
OverweightOverweight
BTIG2025-11-04
Maintains
BuyBuy
Morgan Stanley2025-11-04
Maintains
OverweightOverweight
UBS2025-11-04
Maintains
NeutralNeutral

Wall Street analysts have recently issued updated ratings on IDEXX Laboratories, Inc. (IDXX) stock. Of the recent 133 rating actions, 6 were upgrades and 7 were downgrades. 22 analysts currently cover IDXX.

Analyst Recommendation Trends

Buy ratings303
Hold ratings11
Sell ratings00

IDXX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$4.7B

↓ 15.7% YoY

Revenue Next Year

$5.1B

↑ 8.8% YoY

EPS This Year

$14.66

EPS Next Year

$16.57

↑ 13.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast IDXX EPS of $14.66 for the current fiscal year, based on estimates from 11 analysts. The IDXX revenue forecast is $4.7B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The IDXX stock forecast is supported by two independent data sources: analyst consensus ratings from 22 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus IDXX price target is $747.50 (+32.9% upside), with an analyst consensus of Buy.

The IDXX short-term stock prediction for tomorrow is $568.04 (+1.03%). The IDXX stock price prediction for 2027 estimates an average of $488. The IDXX stock prediction for 2030 projects a range of $392–$421.

IDEXX Laboratories, Inc. trades on NASDAQ under the ticker IDXX. The IDXX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 59% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

IDXX forecast · 8 questions

According to 22 Wall Street analysts, the average 12-month IDXX price target is $747.50, with a high forecast of $800.00 and a low of $640.00. The median price target is shown in the chart above when available. This implies +32.9% potential upside from the current price of $562.27.

IDXX price targetWhat is IDXX price targetIDXX analyst price targetIDXX 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.